Company intelligence / Profile preview

Indaco Venture Partners

Ownership: Private
Employees: ~35
Development stage: Other

Overview

Indaco Venture Partners is Italy’s largest independent venture capital asset management company specializing in investments in innovative technology sectors including medtech, biotech-pharma, digital technologies, electronics and robotics. Through its dedicated funds—such as the Indaco Bio fund—it supports growth-stage companies developing proprietary technologies and novel therapeutics. The firm has backed several clinical-stage biotechs through specialized funds[1][2][4].

Modalities: Small moleculeMonoclonal antibodyGene therapy
Industry: Investors

Partnerships

Cariplo FactoryUniversity of Milan

Beyond the preview

Go deeper on Indaco Venture Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Indaco Venture Partners.

Explore the full profile